Bosulif

DRUG2 trials

Sponsors

University of Bonn, Pfizer

Conditions

Chronic Leukemia MyelogenousChronic Myelogenous Leukaemia

Phase 2

Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients

University of BonnChronic Myelogenous Leukaemia

Start: 2016-03-31End: 2019-10-31Target: 127Updated: 2017-07-02

Unknown Phase

A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).

RecruitingNCT06297161

PfizerChronic Leukemia Myelogenous

Start: 2025-01-20End: 2028-06-01Target: 600Updated: 2026-04-14

Related Papers

Second-Line Bosutinib Is Effective and Feasible in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) - an Analysis of a Subcohort of the Bodo Trial (CML-VII-study of the German CML Study Group)

Blood2024-11-05